亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

New Perspectives in Type 2 Diabetes, Cardiovascular Risk, and Treatment Goals

作者
Carol Wysham
出处
期刊:Postgraduate Medicine [Taylor & Francis]
卷期号:122 (3): 52-60 被引量:22
标识
DOI:10.3810/pgm.2010.05.2142
摘要

Diabetes mellitus is a complex and increasingly common metabolic disease that is characterized by hyperglycemia and associated with microvascular and macrovascular complications. Approximately 90% of patients with diabetes have type 2 diabetes. Obesity and type 2 diabetes are intricately linked, with weight gain being a major contributor to the increasing incidence of type 2 diabetes. Both conditions are independent risk factors for cardiovascular disease, which is the cause of death for the majority (65%) of patients with diabetes. Data from recent large-scale outcomes trials continue to clarify the role of glucose-lowering therapy for patients with type 2 diabetes and increased risk of cardiovascular disease. This serves to further underscore the importance of an individualized treatment approach that takes duration of disease, presence of complications and comorbidities, and the potential adverse risks of therapy into consideration. Although the currently available antidiabetes medications are effective in lowering glucose, some of these agents, including insulin, sulfonylureas, and thiazolidinediones, are often limited by weight gain and/or hypoglycemia. Expert panel guidelines recommend a comprehensive approach that targets the traditional risk factors (glucose, weight, blood pressure, lipids) as the ideal treatment strategy to prevent complications of type 2 diabetes. Incretin-based therapies, including the glucagon-like peptide-1 receptor agonists, target the fundamental defects of type 2 diabetes, reduce glycosylated hemoglobin and body weight, and have potentially beneficial effects on blood pressure, lipids, and other surrogate markers, leading to reduced cardiovascular risk. Physicians should be encouraged to adopt a therapeutic approach with individualized patient goals. By reinforcing the role of patients with type 2 diabetes in treatment decisions, better compliance and achievement of treatment goals can be achieved.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
学术雷锋发布了新的文献求助10
1秒前
EllenLawliet发布了新的文献求助10
4秒前
风中柚子完成签到 ,获得积分10
5秒前
6秒前
Ww完成签到,获得积分10
8秒前
fangmu完成签到,获得积分10
10秒前
无限的寡妇完成签到,获得积分10
10秒前
12秒前
深情安青的应助被Gary采纳,获得10
13秒前
14秒前
14秒前
Foloydon完成签到,获得积分10
15秒前
LX有理想发布了新的文献求助10
16秒前
17秒前
Foloydon发布了新的文献求助10
18秒前
机灵的月光完成签到,获得积分10
18秒前
科研民工完成签到,获得积分10
23秒前
上官若男的应助被Peter采纳,获得10
25秒前
30秒前
31秒前
31秒前
朱雀发布了新的文献求助10
38秒前
Akim的应助被LX有理想采纳,获得10
39秒前
39秒前
40秒前
42秒前
椰子云发布了新的文献求助10
42秒前
yangyang完成签到 ,获得积分10
42秒前
文艺的幼丝完成签到,获得积分10
45秒前
47秒前
50秒前
LX有理想发布了新的文献求助10
52秒前
超帅的若剑完成签到,获得积分10
54秒前
Yuantian发布了新的文献求助20
55秒前
56秒前
第二支羽毛完成签到,获得积分10
1分钟前
1分钟前
共享精神的应助被科研通管家采纳,获得10
1分钟前
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158598
求助须知:如何正确求助?哪些是违规求助? 9554358
关于积分的说明 21719087
捐赠科研通 7748128
什么是DOI,文献DOI怎么找? 3427032
关于科研通互助平台的介绍 2551902
邀请新用户注册赠送积分活动 2471277